timothy sykes logo
G Google News

TRLV Slides As Traders Focus On Weak Momentum And Margins

JACK KELLOGG•UPDATED JUN. 13, 2026, 11:09 AM ET
Reviewed by Tim Sykesand Fact-checked by Ellis Hobbs

Trulieve Cannabis Corp. Subordinate stocks have been trading down by -10.82 percent amid heightened regulatory and legalization uncertainty.

Market Insights For Active TRLV Traders

  • Price has dropped from the $12 area toward $10, showing clear short-term selling pressure.
  • Intraday action reveals a sharp fade from early levels, signaling aggressive supply.
  • Margins remain mixed, with strong gross margin but negative net profit, keeping sentiment cautious.
  • Cash and liquidity look solid, giving Trulieve Cannabis Corp. Subordinate room to operate despite losses.
  • Traders are watching whether the $10 zone can act as a short-term support base.

Candlestick Chart

Weekly Update Jun 08 – Jun 12, 2026: On Saturday, June 13, 2026 Trulieve Cannabis Corp. Subordinate stock [NYSE: TRLV] is trending down by -10.82%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Healthcare industry expert:

Analyst sentiment – neutral

TRLV operates as a mid-cap healthcare services/platform asset with solid top-line scale (~$1.18B revenue) and strong gross margin near 60%, but negative consolidated profitability (profit margin ~-7%, ROE ~-7–10%). EBITDA margin of 28% and EBIT margin of 13% indicate attractive unit economics, yet heavy below-the-line charges and interest (coverage 5.5x) suppress net income. Balance sheet quality is good: current ratio 5.3, modest leverage (total debt/equity 0.54), and robust liquidity with ~$353M cash and healthy free cash flow (~$56M Q1).

Technically, TRLV is in a short-term downtrend: the sequence from 11.70 to 11.37 to 10.30 shows accelerating downside with lower highs and lower lows on the weekly tape. The break under 11.00 triggered heavier selling on intraday 5-minute candles, with volume expanding into weakness, confirming distribution rather than a shakeout. Primary actionable level is resistance at 11.40–11.70; below this band, rallies should be sold. Initial demand appears only near 10.10–10.20, which is the first meaningful support zone.

With no new company-specific news, TRLV trades primarily on execution versus expectations and sector flows. Relative to healthcare and pharma benchmarks, its growth plus FCF profile is competitive, but negative GAAP returns keep it in a “show-me” bucket. I expect range-bound to slightly positive performance, anchored by strong liquidity and cash generation. Near-term support sits at 10.10–10.20, resistance at 11.40–11.70; a 12-month fair-value band of $12–$13 is justified if margins normalize and net profitability improves.

More Breaking News

Quick Financial Overview

Trulieve Cannabis Corp. Subordinate (TRLV) shows a stock that has been under steady pressure on the weekly chart. Price recently failed to hold above the low $12s and slid toward the $10 area, which tells you sellers are still in control. The weekly range has narrowed, reflecting a market that is searching for a new balance after this pullback.

On the intraday 5‑minute view, TRLV opened in the mid‑$11s but quickly faded toward the low $10s. That kind of intraday reversal, from near the top of the recent weekly range down to near the lows, is a classic momentum shift signal. For short-term traders, that move suggests strength on bounces is being sold rather than accumulated.

Financially, Trulieve Cannabis Corp. Subordinate is a mixed picture. Revenue is around $1.18B, and gross margin near 59.7% shows the core business can produce solid markups. But net margins are negative, with profit margin near -6.98% and return on equity in the red, pointing to ongoing drag from costs, taxes, or structure. Liquidity is strong, with a current ratio above 5 and a quick ratio near 3, plus over $350M in cash, which reduces near-term distress risk but does not solve profitability issues.

Conclusion

This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Our content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to us for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize our news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities.

Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles:

Once you’ve got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market’s twists and turns.
Dig into StocksToTrade’s watchlists here:

How much has this post helped you?

(0 votes, average: 0 out of 5)
Leave a reply

Click Here for a Millionaire's POV on Trading TRLV

Millionaire's
POV on TRLV

Don't miss the next
big breakout.

GET POV
Tim Sykes

* Results are not typical and will vary from person to person. Making money trading stocks takes time, dedication, and hard work. There are inherent risks involved with investing in the stock market, including the loss of your investment. Past performance in the market is not indicative of future results. Any investment is at your own risk. See Terms of Service here

The available research on day trading suggests that most active traders lose money. Fees and overtrading are major contributors to these losses.

A 2000 study called “Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors” evaluated 66,465 U.S. households that held stocks from 1991 to 1996. The households that traded most averaged an 11.4% annual return during a period where the overall market gained 17.9%. These lower returns were attributed to overconfidence.

A 2014 paper (revised 2019) titled “Learning Fast or Slow?” analyzed the complete transaction history of the Taiwan Stock Exchange between 1992 and 2006. It looked at the ongoing performance of day traders in this sample, and found that 97% of day traders can expect to lose money from trading, and more than 90% of all day trading volume can be traced to investors who predictably lose money. Additionally, it tied the behavior of gamblers and drivers who get more speeding tickets to overtrading, and cited studies showing that legalized gambling has an inverse effect on trading volume.

A 2019 research study (revised 2020) called “Day Trading for a Living?” observed 19,646 Brazilian futures contract traders who started day trading from 2013 to 2015, and recorded two years of their trading activity. The study authors found that 97% of traders with more than 300 days actively trading lost money, and only 1.1% earned more than the Brazilian minimum wage ($16 USD per day). They hypothesized that the greater returns shown in previous studies did not differentiate between frequent day traders and those who traded rarely, and that more frequent trading activity decreases the chance of profitability.

These studies show the wide variance of the available data on day trading profitability. One thing that seems clear from the research is that most day traders lose money .

Millionaire Media 66 W Flagler St. Ste. 900 Miami, FL 33130 United States (888) 878-3621 This is for information purposes only as Millionaire Media LLC nor Timothy Sykes is registered as a securities broker-dealer or an investment adviser. No information herein is intended as securities brokerage, investment, tax, accounting or legal advice, as an offer or solicitation of an offer to sell or buy, or as an endorsement, recommendation or sponsorship of any company, security or fund. Millionaire Media LLC and Timothy Sykes cannot and does not assess, verify or guarantee the adequacy, accuracy or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. Millionaire Media LLC and Timothy Sykes in no way warrants the solvency, financial condition, or investment advisability of any of the securities mentioned in communications or websites. In addition, Millionaire Media LLC and Timothy Sykes accepts no liability whatsoever for any direct or consequential loss arising from any use of this information. This information is not intended to be used as the sole basis of any investment decision, nor should it be construed as advice designed to meet the investment needs of any particular investor. Past performance is not necessarily indicative of future returns.

Citations for Disclaimer

Barber, Brad M. and Odean, Terrance, Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors. Available at SSRN: “Day Trading for a Living?”

Barber, Brad M. and Lee, Yi-Tsung and Liu, Yu-Jane and Odean, Terrance and Zhang, Ke, Learning Fast or Slow? (May 28, 2019). Forthcoming: Review of Asset Pricing Studies, Available at SSRN: “https://ssrn.com/abstract=2535636”

Chague, Fernando and De-Losso, Rodrigo and Giovannetti, Bruno, Day Trading for a Living? (June 11, 2020). Available at SSRN: “https://ssrn.com/abstract=3423101”